SCHEMBL564600

SCHEMBL564600

Nc1ccc(Nc2ccccc2)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
MAPT P10636 6/20 0.54
CYP3A4 P08684 5/20 0.54
ALOX12 P18054 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
HTT P42858 1/20 0.54
GAA P10253 4/20 0.53
KDM4E B2RXH2 4/20 0.53
TDP1 Q9NUW8 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
TSHR P16473 3/20 0.53
GFER P55789 2/20 0.53
LMNA P02545 2/20 0.53
HSD17B10 Q99714 5/20 0.52
ALOX15 P16050 4/20 0.52
PTGS1 P23219 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477516 0.96 ALDH1A1 (0.59) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1
SCHEMBL565079 0.89 ALOX15 (0.54) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1
SCHEMBL563875 0.86 CYP3A4 (0.67) ALDH1A1MAPTCYP3A4L3MBTL1HTT
SCHEMBL564670 0.86 CYP3A4 (0.52) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1
SCHEMBL565035 0.85 MAPT (0.60) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1
SCHEMBL564726 0.85 CYP3A4 (0.60) ALDH1A1MAPTCYP3A4ALOX12CYP1A2
SCHEMBL564969 0.84 CYP3A4 (0.59) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1
SCHEMBL4530935 0.81 CYP3A4 (0.59) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1
SCHEMBL5088671 0.81 ALDH1A1 (0.60) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1
SCHEMBL7555415 0.76 HPGD (0.54) ALDH1A1MAPTCYP3A4ALOX12L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674029-B2 Method of preparing stabilized polymeric systems using polymeric peroxides Sunocs LLC (US) 2014-03-18 US disclosed
US-20120035307-A1 PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES SONG CHENGQIAN (US) 2012-02-09 US disclosed
US-20120035315-A1 METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES SONG CHENGQIAN (US) 2012-02-09 US disclosed
US-7498467-B2 Antioxidant and bisaminophenol derivative IDEMITSU KOSAN CO., LTD. (JP) 2009-03-03 US disclosed
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-07-03 US disclosed
US-20060208227-A1 Antioxidant and bisaminophenol derivative IDEMITSU LOSAN CO., LTD (JP) 2006-09-21 US disclosed
EP-1612254-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN COMPANY LIMITED (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE CBR1, CBR3, HMOX1 ALDH1A1 204/4885MAPT 3886/4885CYP3A4 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.